treatment

For patients with myelodysplastic neoplasm/syndrome (MDS), allogeneic hematopoietic cell transplantation (allo-HCT) represents the only potentially curative treatment, capable of eradicating disease-related mutant hematopoietic cells and establishing normal donor hematopoiesis.

A roundtable discussion on anemia management in

ABSTRACT
Over the last decade, there have been significant advancements in the treatment for patients with

Significant progress in the characterization of molecular pathogenic events in

A roundtable discussion on anemia management in

Key Points
The ICC and WHO5 differently classify 64% of TP53-mutated disease due to distinct criteria for multihit TP53 mutations and TP53-mutated AML.

Interim results of the ACROBAT study suggest that increasing microchimerism and loss of complete chimerism may indicate relapse risk in patients with

Abstract